290 related articles for article (PubMed ID: 23134549)
41. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention.
Ahmed RM; Mohamed el-HA; Ashraf M; Maithili S; Nabil F; Rami R; Mohamed TI
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E647-53. PubMed ID: 23404916
[TBL] [Abstract][Full Text] [Related]
42. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
[TBL] [Abstract][Full Text] [Related]
43. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
[TBL] [Abstract][Full Text] [Related]
44. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
[TBL] [Abstract][Full Text] [Related]
45. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
[TBL] [Abstract][Full Text] [Related]
46. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform.
Orak M; Ustündağ M; Güloğlu C; Ozhasenekler A; Alyan O; Kale E
Am J Emerg Med; 2010 Oct; 28(8):891-6. PubMed ID: 20825920
[TBL] [Abstract][Full Text] [Related]
47. [Study on the relationship between aspirin resistance and incidence of myonecrosis after non-emergent percutaneous coronary intervention].
Zhang Y; Liang J; Zhou YJ; Yuan H; Zhang YZ; Dong L
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):695-9. PubMed ID: 16188050
[TBL] [Abstract][Full Text] [Related]
48. [Identification and diagnosis of myocardial damage and acute myocardial infarction during cardiopulmonary resuscitation].
Wang JG; Kong DQ; Huang Y; Huang JY; Zhang ZL; Wu WC; Pan XW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):333-6. PubMed ID: 19570336
[TBL] [Abstract][Full Text] [Related]
49. Study of CK-MB activity in patients with acute myocardial infarction after percutaneous coronary intervention.
Emukhvari NM; Tsetsekhladze ED; Khijakadze KhA; Mamatsashvili IO; Napetvaridze RG
Georgian Med News; 2015 Feb; (239):47-51. PubMed ID: 25802449
[TBL] [Abstract][Full Text] [Related]
50. [Relation of plasma brain natriuretic peptide to serum creatine kinase MB level in patients with acute myocardial infarction following primary percutaneous coronary intervention].
Xiao ZH; Yang XL; Tan HB; Chen J; Xu ZY; Zhang JY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1665-6. PubMed ID: 17121728
[TBL] [Abstract][Full Text] [Related]
51. Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial.
Leonardi S; Stebbins A; Lopes RD; Lokhnygina Y; Todd M; Bhatt DL; Stone GW; Lincoff AM; Dauerman HL; Gibson CM; White HD; Parikh KH; Gruberg L; Herrmann HC; McLaurin BT; Goodman SG; Mahaffey KW
Coron Artery Dis; 2013 Jun; 24(4):321-7. PubMed ID: 23442944
[TBL] [Abstract][Full Text] [Related]
52. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
[TBL] [Abstract][Full Text] [Related]
53. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
[TBL] [Abstract][Full Text] [Related]
54. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
[TBL] [Abstract][Full Text] [Related]
55. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
56. Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.
Zhou FZ; Song W; Yin LH; Song ZF; Yang S; Yang FB; Liu JF; Song YG; Zhang HY; Zhang ZM
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4642-4648. PubMed ID: 29131250
[TBL] [Abstract][Full Text] [Related]
57. Anti-oxidative stress effect of loading-dose rosuvastatin prior to percutaneous coronary intervention in patients with acute coronary syndrome: a prospective randomized controlled clinical trial.
Liang D; Zhang Q; Yang H; Zhang R; Yan W; Gao H; Wang J; Zhang X; Chen Y; Cao F
Clin Drug Investig; 2014 Nov; 34(11):773-81. PubMed ID: 25186834
[TBL] [Abstract][Full Text] [Related]
58. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention.
Shehata M
Minerva Cardioangiol; 2014 Dec; 62(6):461-71. PubMed ID: 24699551
[TBL] [Abstract][Full Text] [Related]
59. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
[TBL] [Abstract][Full Text] [Related]
60. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
